Biotech Investors & VC Firms in China

202 firms in this list, with a median first check of $1.1M. 30 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
MO Morningside Group KS1 person	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
EP ePlanet Capital AAAJYL3 people	88🔒	San Jose	US	Seed–Late Stage	—	+ Add to CRM
CH China Development Industrial Bank (CDIB)	88🔒	Taipei	TW	Series A–Series B	$2.8M – $51M	+ Add to CRM
HO Hong Kong Science and Technology Parks – incubation programs	88🔒	Hong Kong	HK	Pre-Seed–Growth	$13K – $100M	+ Add to CRM
CB CBC Group WFJM2 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
NA Nan Fung Life Sciences VC1 person	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
SH ShangPharma Innovation RDYX2 people	88🔒	South San Francisco	US	Seed–Series A	—	+ Add to CRM
HS HSBC Innovation Ventures YQ1 person	88🔒	London	GB	Seed–Growth	—	+ Add to CRM
LA Lake Bleu Capital	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
HO Hong Kong X Technology Fund	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM

Morningside Group

Hong KongSeed–Growth

KS1 person

ePlanet Capital

San JoseSeed–Late Stage

AAAJYL3 people

China Development Industrial Bank (CDIB)

TaipeiSeries A–Series B$2.8M – $51M

Hong Kong Science and Technology Parks – incubation programs

Hong KongPre-Seed–Growth$13K – $100M

CBC Group

SingaporeSeed–Late Stage

WFJM2 people

Nan Fung Life Sciences

Hong KongSeed–Growth

VC1 person

ShangPharma Innovation

South San FranciscoSeed–Series A

RDYX2 people

HSBC Innovation Ventures

LondonSeed–Growth

YQ1 person

Lake Bleu Capital

Hong KongSeed–Growth

Hong Kong X Technology Fund

Hong KongSeed–Growth

Data sourced from public filings and firms' own websites — see our methodology.